enGene Holdings Inc. Income Statement

Income Statement Oct2022 Oct2023 Oct2024 Oct2025
Revenue & cost
Revenue -1.42M-4.95M-2.80M-2.99M
Operating items
Research & Development 15.47M16.46M38.31M94.48M
Selling, General & Administrative 3.96M9.60M23.98M28.68M
Restructuring Costs 11.95M11.47M
Other Operating Expenses -11.95M-11.47M
Operating Expenses 19.43M26.06M62.30M123.17M
Operating Income -19.43M-26.06M-62.30M-123.17M
EBIT -19.43M-26.06M-62.30M-123.17M
Non-operating items
Interest & Investment Income 0.13M1.12M10.41M9.43M
Other Non Operating Income -0.66M-0.13M-0.37M-0.57M
Non Operating Income -5.01M-73.84M7.14M5.86M
Net income details
EBT -24.44M-99.90M-55.16M-117.30M
Tax Provisions 0.02M0.02M-0.02M
Profit After Tax -24.46M-99.92M-55.14M-117.30M
Income from Continuing Operations -24.46M-99.92M-55.14M-117.30M
Consolidated Net Income -24.46M-99.92M-55.14M-117.30M
Income towards Parent Company -24.46M-99.92M-55.14M-117.30M
Net Income towards Common Stockholders -29.02M-104.74M-55.14M-117.30M
Additional items
EPS (Basic) 44.30151.221.462.29
EPS (Weighted Average and Diluted) 44.30151.221.462.29
Shares Outstanding (Weighted Average) 15.81M23.20M44.22M51.19M
EBITDA -23.30M-99.92M-54.74M-116.77M
Interest Expenses 1.42M4.95M2.80M2.99M
Tax Rate 0.03%